Technology behind commercial devices for blood glucose monitoring in diabetes management: A review

Sandeep Kumar Vashist; Dan Zheng; Khalid Al-Rubeaan; John H.T. Luong; Fwu Shan Sheu

doi:10.1016/j.aca.2011.07.024

Technology behind commercial devices for blood glucose monitoring in diabetes management: A review

Sandeep Kumar Vashist
, Dan Zheng
, Khalid Al-Rubeaan
, John H.T. Luong
, Fwu Shan Sheu

School of Chemistry

Research output: Contribution to journal › Short survey › peer-review

Abstract

The blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed.

Original language	English
Pages (from-to)	124-136
Number of pages	13
Journal	Analytica Chimica Acta
Volume	703
Issue number	2
DOIs	https://doi.org/10.1016/j.aca.2011.07.024
Publication status	Published - 10 Oct 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Blood glucose monitoring devices
Electron mediators
Glucose limiting membranes
Glucose strips
Interferences

Access to Document

10.1016/j.aca.2011.07.024

Cite this

@article{ed82576130cc41eeadc89653a9826799,

title = "Technology behind commercial devices for blood glucose monitoring in diabetes management: A review",

abstract = "The blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed.",

keywords = "Blood glucose monitoring devices, Electron mediators, Glucose limiting membranes, Glucose strips, Interferences",

author = "Vashist, \{Sandeep Kumar\} and Dan Zheng and Khalid Al-Rubeaan and Luong, \{John H.T.\} and Sheu, \{Fwu Shan\}",

year = "2011",

month = oct,

day = "10",

doi = "10.1016/j.aca.2011.07.024",

language = "English",

volume = "703",

pages = "124--136",

journal = "Analytica Chimica Acta",

issn = "0003-2670",

publisher = "Elsevier B.V.",

number = "2",

}

TY - JOUR

T1 - Technology behind commercial devices for blood glucose monitoring in diabetes management

T2 - A review

AU - Vashist, Sandeep Kumar

AU - Zheng, Dan

AU - Al-Rubeaan, Khalid

AU - Luong, John H.T.

AU - Sheu, Fwu Shan

PY - 2011/10/10

Y1 - 2011/10/10

N2 - The blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed.

AB - The blood glucose monitoring devices (BGMDs) are an integral part of diabetes management now-a-days. They have evolved tremendously within the last four decades in terms of miniaturization, rapid response, greater specificity, simplicity, minute sample requirement, painless sample uptake, sophisticated software and data management. This article aims to review the developments in the technologies behind commercial BGMD, especially those in the areas of chemistries, mediators and other components. The technology concerns, on-going developments and future trends in blood glucose monitoring (BGM) are also discussed.

KW - Blood glucose monitoring devices

KW - Electron mediators

KW - Glucose limiting membranes

KW - Glucose strips

KW - Interferences

UR - https://www.scopus.com/pages/publications/81155160141

U2 - 10.1016/j.aca.2011.07.024

DO - 10.1016/j.aca.2011.07.024

M3 - Short survey

C2 - 21889626

AN - SCOPUS:81155160141

SN - 0003-2670

VL - 703

SP - 124

EP - 136

JO - Analytica Chimica Acta

JF - Analytica Chimica Acta

IS - 2

ER -

Technology behind commercial devices for blood glucose monitoring in diabetes management: A review

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this